The global market for mobile health smartphone applications exploded last year, growing seven-fold to $718 million, according to a new report.
Still, the mobile health (or is it digital health?) market is in its “embryonic” state, meaning it’s nowhere close to reaching its potential, according to the report from research2guidance.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
At a high level, the reasons behind the huge surge in mobile health growth are rather obvious: an increase in demand for health apps from a world that’s buying more and more smartphones, and, on the supply side, a doubling of the number of mobile health apps available to the public.
“A majority of the major healthcare companies have discovered mHealth applications as an innovative way to promote and deliver healthcare services and products,” according to research2guidance.
A summary of the report highlighted one big-company mobile health app in particular: Sanofi-Aventis’ iBGStar diabetes monitoring app.
The app received U.S. regulatory approval in December and is marketed as the first and only blood glucose meter that connects directly to the iPhone or iPod Touch.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
